Llwytho...
Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives
Fenretinide (4-HPR) is a synthetic retinoid that has cytotoxic activity against cancer cells. Despite substantial in vitro cytotoxicity, response rates in early clinical trials with 4-HPR have been less than anticipated, likely due to the low bioavailability of the initial oral capsule formulation....
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Exp Biol Med (Maywood) |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5478002/ https://ncbi.nlm.nih.gov/pubmed/28429653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217706952 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|